Skip to Content

'
Gregory M Chronowski, M. D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
Regional Care Center Katy
19770 Kingsland Blvd.
Unit Number: 2050
Katy, TX 77094
Phone: 713-563-9600
Fax: 281-647-2802

Education & Training

Degree-Granting Education

1998 Jefferson Medical College, Philadelphia, PA, MD, Medicine
1992 Columbia University, New York, NY, Pre Medical, Pre Medical
1990 Union College, Schenectady, NY, BS, Biology

Selected Publications

Peer-Reviewed Original Research Articles

1. Frank SJ, Rosenthal DI, Petsuksiri J, Ang KK, Morrison WH, Weber RS, Glisson BS, Chao KS, Schwartz DL, Chronowski GM, El-Naggar AK, Garden AS. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 78(4):1005-10, 11/15/2010. e-Pub 3/6/2010. PMID: 20207504.
2. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. Prospective imaging assessment of mortality risk after head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys 78(3):667-74, 11/1/2010. e-Pub 2/18/2010. PMCID: PMC3072063.
3. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 27(15):2509-15, 5/20/2009. e-Pub 3/30/2009. PMCID: PMC2739610.
4. Chao KS, Bhide S, Chen H, Asper J, Bush S, Franklin G, Kavadi V, Liengswangwong V, Gordon W, Raben A, Strasser J, Koprowski C, Frank S, Chronowski G, Ahamad A, Malyapa R, Zhang L, Dong L. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys 68(5):1512-21, 8/1/2007. PMID: 17674982.
5. Chronowski GM, Buchholz TA. Accelerated partial breast irradiation. Curr Probl Cancer 31(1):7-25, Jan-Feb, 1/2007. PMID: 17254900.
6. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62(1):131-7, 5/1/2005. PMID: 15850913.
7. Jagsi R, Chronowski GM, Buck DA, Kang S, Palermo J, Association of Residents in Radiation Oncology Executive Committee. Special report: results of the 2000-2002 Association of Residents in Radiation Oncology (ARRO) surveys. Int J Radiat Oncol Biol Phys 59(1):313-8, 5/1/2004. PMID: 15093928.
8. Chronowski GM, Wilder RB, Levy LB, Atkinson EN, Ha CS, Hagemeister FB, Barista I, Rodriguez MA, Sarris AH, Hess MA, Cabanillas F, Cox JD. Second malignancies after chemotherapy and radiotherapy for Hodgkin disease. Am J Clin Oncol 27(1):73-80, 2/2004. PMID: 14758137.
9. Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy. Int J Radiat Oncol Biol Phys 55(1):36-43, 1/1/2003. PMID: 12504034.
10. Chronowski GM, Wilder RB, Tucker SL, Ha CS, Sarris AH, Hagemeister FB, Barista I, Hess MA, Cabanillas F, Cox JD. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease. Cancer 95(12):2534-8, 12/15/2002. PMID: 12467067.
11. Wilder RB, Schlembach PJ, Jones D, Chronowski GM, Ha CS, Younes A, Hagemeister FB, Barista I, Cabanillas F, Cox JD. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease. Cancer 94(6):1731-8, 3/15/2002. PMID: 11920535.
12. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 92(3):670-6, 8/2001. PMID: 11505414.
13. Laurie SA, Pfister DG, Kris MG, Tong WP, Chronowski G, Pisters KM, Heelan RT, Sirotnak FM. Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin. Clin Cancer Res 7(3):501-9, 3/2001. PMID: 11297240.

Last updated: 7/23/2013